1. Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial. (April 2022) Authors: Putananickal, Niveditha; Gross, Elena C; Orsini, Anna-Lena; Schmidt, Simone; Hafner, Patricia; Gocheva, Vanya; Nagy, Sara; Henzi, Bettina C; Rubino, Daniela; Vogt, Deborah R; Cichon, Sven; Sandor, Peter; Fischer, Dirk Journal: Cephalalgia Issue: Volume 42:Number 4/5(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗